Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression

NCT06591091 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT06591091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06591091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression
Lead sponsor
University of Illinois at Chicago
Phase
Phase 2
Overall status
Recruiting
Start date
December 10, 2025
Completion date
December 31, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression